Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Arvind Suresh, Maeen N. Arslan, Heather A. Wishart, Amy M. Chan, Bryce S. Jacobson, Grant Moncrief, Christopher H. Lowrey, Christi Ann Hayes, Susan C. Brighton, Dorothy R. McKenna, Lisa J. Wesinger, Judi A. Gentes, Kate L. Caldon, Zbigniew M. Szczepiorkowski, Kenneth R. Meehan, John M. Hill, Jr.

Blood (2022) 140 (Supplement 1): 4686–4687.

https://doi.org/10.1182/blood-2022-168112

Published: 2022

Journal Articles

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Christi Ann Hayes, Kenneth R. Meehan, Elizabeth A O'Donnell, Aricca Van Citters, Kate L. Caldon, Charlotte M Coughenour, Dorothy R. McKenna, Carla Tarzia, Wenyan Zhao, Kimberley R Holt, Christopher H. Lowrey, John M. Hill, Jr., Tiffany D'Cruze, Megan M Holthoff, Tor Tosteson, Anna Tosteson

Blood (2022) 140 (Supplement 1): 8113–8114.

https://doi.org/10.1182/blood-2022-163437

Published: 2022

Journal Articles

Imetelstat-Mediated Alterations in Lipid Metabolism to Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 487–488.

https://doi.org/10.1182/blood-2022-168166

Published: 2022

Journal Articles

Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment

Takumi Kobayashi, Pui Yeng Lam, Hui Jiang, Karolina Bednarska, Renee Gloury, Valentine Murigneux, Joshua Tay, Nicolas Jacquelot, Rui Li, Zewen Kelvin Tuong, Graham R. Leggatt, Maher K. Gandhi, Michelle M. Hill, Gabrielle T. Belz, Shyuan Ngo, Axel Kallies, Stephen R. Mattarollo

Blood (2020) 136 (26): 3004–3017.

https://doi.org/10.1182/blood.2020005602

Published: 2020

Includes: Supplemental data

Journal Articles

Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma

Michael S. Khodadoust, MD PhD, Tatyana A. Feldman, MD, Dok Hyun Yoon, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Dejan Radeski, MBBS, FRACP, FRCPA, Youn H. Kim, MD, Neha Mehta-Shah, MD, Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Ryan A. Wilcox, MD, Won Seog Kim, MD PhD, Steven M. Horwitz, MD, Joseph J. Buggy, PhD, Andrew Hotson, PhD, Craig M. Hill, PhD, Brian Munneke, PhD, Suresh Mahabhashyam, MD, Richard A. Miller, MD, James W. Janc, PhD, Mehrdad Mobasher, MDMPH

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-137782

Published: 2020

Journal Articles

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

V. Koneti Koneti Rao, MD FRCPA, Patrick P. Ng, PhD, Craig M. Hill, PhD, Richard A. Miller, MD, Joseph J. Buggy, PhD, James W. Janc, PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-137631

Published: 2020

Journal Articles

Preliminary Clinical Data from a Phase 1 Trial with CPI-818, a Selective ITK Inhibitor That Preferentially Blocks the Growth of T Lymphoma Cells

Patrick P. Ng, PhD, Mehrdad Mobasher, MD MPH, Kitman S. Yeung, MS, Andrew N. Hotson, PhD, Craig M. Hill, PhD, Antonett Madriaga, MS, Trang P. Dao-Pick, MA, Erik Verner, PhD, Dejan Radeski, MBBS, FRACP, FRCPA, Michael S. Khodadoust, MD PhD, Youn H. Kim, MD, Richard A. Miller, MD, Joseph J. Buggy, PhD, James W. Janc, PhD

Blood (2019) 134 (Supplement_1): 1571.

https://doi.org/10.1182/blood-2019-127338

Published: 2019

Journal Articles

Peripheral Blood Chimerism Can Replace Marrow Chimerism Analyses Following Adult Allogeneic Stem Cell Transplant.

Cocav Rauwerdink, MD, Gregory J Tsongalis, PhD, John M. Hill, Jr., MD, Kenneth R Meehan, MD

Blood (2009) 114 (22): 4316.

https://doi.org/10.1182/blood.V114.22.4316.4316

Published: 2009

Journal Articles

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Kenneth R Meehan, MD, John M. Hill, Jr., MD, Marc Ernstoff, MD, Charles L Sentman, MD

Blood (2008) 112 (11): 3491.

https://doi.org/10.1182/blood.V112.11.3491.3491

Published: 2008

Journal Articles

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, Lynn D. Root, Elizabeth A. Kimtis, Idalina C. Williams, Marc S. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, Charles L. Sentman, PhD, Kenneth R. Meehan, MD

Blood (2007) 110 (11): 5120.

https://doi.org/10.1182/blood.V110.11.5120.5120

Published: 2007

Journal Articles

Transplantation in the Elderly: The Affect of Age on Clinical Course and Outcomes.

Marcy Canary, MD, John M. Hill, MD, Kenneth R. Meehan, MD

Blood (2007) 110 (11): 5114.

https://doi.org/10.1182/blood.V110.11.5114.5114

Published: 2007

Journal Articles

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Jia-Yan Wu, PhD, Susan M. Webber, BS MT(ASAP) BB, John M. Hill, MD, Marc Ernstoff, MD, Zbigniew Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5232.

https://doi.org/10.1182/blood.V108.11.5232.5232

Published: 2006

Journal Articles

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

John M. Hill, MD, Jia-Yan Wu, PhD, Susan M. Webber, BS, MT(ASAP), BB, Ortal Sharlin, Melinda Kendall, David McGregor, MT(ASCP), Marc J. Ernstoff, MD, Zbigniew M. Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD

Blood (2006) 108 (11): 5152.

https://doi.org/10.1182/blood.V108.11.5152.5152

Published: 2006

Journal Articles

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

Pamela Ely, MD, PhD, Diane M. Stearns, ARNP, Bassem I. Zaki, MD, Thomas F. Fitzmaurice, Ph.D, Marc Gautier, MD, Christopher H. Lowrey, MD, Elizabeth M. Bengtson, MD, John M. Hill, MD, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Lynn Root, RN, Susan Webber, MT (ASCP), BB, Zbigniew M. Szczepiorkowski, MD, Ph.D, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 5517.

https://doi.org/10.1182/blood.V106.11.5517.5517

Published: 2005

Journal Articles

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients’ Trust and Assurance.

Elissa F. Malcolm, MS, Linda J. Patchett, RN, MBA, Thomas F. Fitzmaurice, Ph.D, John M. Hill, MD, Kenneth R. Meehan, MD

Blood (2005) 106 (11): 5592.

https://doi.org/10.1182/blood.V106.11.5592.5592

Published: 2005

Journal Articles

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Jia-Yan Wu, Ph.D, John M. Hill, MD, Marc Ernstoff, MD, Kenneth R. Meehan

Blood (2004) 104 (11): 3164.

https://doi.org/10.1182/blood.V104.11.3164.3164

Published: 2004

Journal Articles

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients.

Linda J. Patchett, RN, MBA, John M. Hill, MD, Thomas F. Fitzmaurice, Ph.D, Kenneth R. Meehan, MD

Blood (2004) 104 (11): 5311.

https://doi.org/10.1182/blood.V104.11.5311.5311

Published: 2004

Journal Articles

Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells

Kathleen A. Hinds, Jonathan M. Hill, Erik M. Shapiro, Mikko O. Laukkanen, Alfonso C. Silva, Christian A. Combs, Timothy R. Varney, Robert S. Balaban, Alan P. Koretsky, Cynthia E. Dunbar

Blood (2003) 102 (3): 867–872.

https://doi.org/10.1182/blood-2002-12-3669

Published: 2003

Journal Articles

Identification, cloning, and characterization of a novel human T-cell- specific tyrosine kinase located at the hematopoietin complex on chromosome 5q

S Gibson, B Leung, JA Squire, M Hill, N Arima, P Goss, D Hogg, GB Mills

Blood (1993) 82 (5): 1561–1572.

https://doi.org/10.1182/blood.V82.5.1561.1561

Published: 1993

Journal Articles

Combined Hemophilia and PTC Deficiency

J. M. HILL, ROBERT J. SPEER

Blood (1955) 10 (4): 357–361.

https://doi.org/10.1182/blood.V10.4.357.357

Published: 1955

NARROW

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Imetelstat-Mediated Alterations in Lipid Metabolism to Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia

Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment

Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, Is Well-Tolerated and Active in Patients with T-Cell Lymphoma

The ITK Inhibitor Cpi-818 Blocks Activation of T Cells from Autoimmune Lymphoproliferative Syndrome (ALPS) Patients and Is Active in a Murine Model of ALPS

Preliminary Clinical Data from a Phase 1 Trial with CPI-818, a Selective ITK Inhibitor That Preferentially Blocks the Growth of T Lymphoma Cells

Peripheral Blood Chimerism Can Replace Marrow Chimerism Analyses Following Adult Allogeneic Stem Cell Transplant.

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

Transplantation in the Elderly: The Affect of Age on Clinical Course and Outcomes.

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Immune Mobilization of Autologous Peripheral Blood Progenitor Cells: IL-2 with GM-CSF and G-CSF Results in Effective Mobilization without Delay in Engraftment.

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients’ Trust and Assurance.

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients.

Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells

Identification, cloning, and characterization of a novel human T-cell- specific tyrosine kinase located at the hematopoietin complex on chromosome 5q

Combined Hemophilia and PTC Deficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only